Perspectives on pharmaceutical manufacturing, capacity planning, and simulation-driven operations.
The promise is seductive: buy one piece of equipment, use it for everything. Maximum flexibility. Minimum capital. In pharmaceutical manufacturing, pooled equipment creates hidden costs that strangle throughput.
Facility design decisions echo for decades. Here's why capacity simulation should happen before the first architectural drawing — not after construction begins.
Most capacity planning is done in spreadsheets. Here's why that fails at scale, and how simulation-driven approaches deliver better investment decisions.
A leading pharmaceutical manufacturer discovered their primary bottleneck was running at 164% utilization — far beyond sustainable. Here's how we found it and what we did.